Acadia Healthcare stock jumps 26% on news that former CEO Debbie Osteen is returning to lead the company, replacing Chris Hunter as the behavioral healthcare provider faces investor pressure.
Capricor Therapeutics shares rise 2% after FDA requests clinical trial data for deramiocel, a potential treatment for Duchenne muscular dystrophy, without requiring new studies.
Corvus Pharmaceuticals announces successful Phase 1 data for soquelitinib, showing significant skin improvement and safety for atopic dermatitis patients.
Novavax secures $30M upfront payment from Pfizer in licensing deal for Matrix-M adjuvant technology, with potential for $500M more in milestone payments.
ImmunityBio advances FDA talks for ANKTIVA in papillary bladder cancer. Treatment shows 96% survival & 80% avoid bladder removal at 3 years, offering hope vs. current option: invasive surgery.
Abivax shares jump 6% on reports of AstraZeneca's €176-per-share offer for the French inflammatory disease drugmaker, adding to ongoing acquisition speculation.
